Holen Sie sich die Stockscreener-App
1.00
26.42%
0.209
Handel nachbörslich:
1.00
Schlusskurs vom Vortag:
$0.791
Offen:
$0.8601
24-Stunden-Volumen:
964.52K
Relative Volume:
7.96
Marktkapitalisierung:
$77.89M
Einnahmen:
$8.88M
Nettoeinkommen (Verlust:
$-4.62M
KGV:
-10.00
EPS:
-0.1
Netto-Cashflow:
$-2.66M
1W Leistung:
+61.26%
1M Leistung:
+28.21%
6M Leistung:
+33.33%
1J Leistung:
+24.02%
1-Tages-Spanne:
$0.83
$1.01
1-Wochen-Bereich:
$0.6001
$1.01
52-Wochen-Spanne:
$0.52
$1.10
Milestone Scientific Inc. Stock (MLSS) Company Profile
Firmenname
Milestone Scientific Inc.
Sektor
Telefon
973-535-2717
Adresse
220 South Orange Avenue, Livingston, NJ
Vergleichen Sie MLSS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MLSS
Milestone Scientific Inc.
|
1.00 | 77.89M | 8.88M | -4.62M | -2.66M | -0.10 |
|
ISRG
Intuitive Surgical Inc
|
542.10 | 192.91B | 7.87B | 2.24B | 586.00M | 4.25 |
|
BDX
Becton Dickinson Co
|
224.25 | 64.77B | 20.18B | 1.73B | 3.07B | 5.51 |
|
ALC
Alcon Inc
|
87.24 | 43.15B | 9.76B | 1.16B | 665.00M | 0.72 |
|
RMD
Resmed Inc
|
249.99 | 36.48B | 4.81B | 1.11B | 1.35B | 6.16 |
|
WST
West Pharmaceutical Services Inc
|
319.35 | 23.17B | 2.88B | 499.60M | 321.60M | 7.41 |
Milestone Scientific Inc. Stock (MLSS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-09-16 | Eingeleitet | Northland Capital | Market Perform |
| 2018-11-16 | Bestätigt | Maxim Group | Buy |
| 2016-12-23 | Bestätigt | Maxim Group | Buy |
| 2015-12-11 | Eingeleitet | Maxim Group | Buy |
Milestone Scientific Inc. Aktie (MLSS) Neueste Nachrichten
Milestone Scientific announces approval on contract for FSS - TipRanks
Milestone Scientific Secures Federal Supply Schedule (FSS) Approval on Contract for CompuFlo® Epidural System - The Manila Times
Milestone Scientific Wins Major Federal Contract for CompuFlo® Epidural System | MLSS Stock News - StockTitan
StockNews.com Initiates Coverage on Milestone Scientific (NYSE:MLSS) - MarketBeat
Scientists achieve major milestone with levitating, virtually limitless energy device: 'A feat in and of itself' - MSN
Benchmark Reaffirms Speculative Buy Rating for Milestone Scientific (NYSE:MLSS) - Defense World
Harvard Bioscience (HBIO) Stock Surges Amid Positive Analyst Rat - GuruFocus.com
MLSS (Milestone Scientific) Total Inventories : $3.71 Mil (As of Sep. 2024) - GuruFocus.com
Milestone Scientific Inc. Reports Q3 2024 Financials - MSN
Milestone Scientific announces CEO transition - MSN
Scientists achieve major milestone in quest for nuclear fusion reactor: 'Holy grail of clean energy' - Yahoo! Voices
StockNews.com Begins Coverage on Milestone Scientific (NYSE:MLSS) - MarketBeat
Chainlink Shatters 238-Day Pattern – Wave Count Signals 100% LINK Price Increase - MSN
Uptown office tower in receivership - MSN
XPeng Inc. Sponsored ADR (XPEV) Increases Despite Market Slip: Here's What You Need to Know - MSN
Milestone Scientific Inc. (AMEX:MLSS) Q3 2024 Earnings Call Transcript - Insider Monkey
Milestone Scientific Inc (MLSS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Challenges - GuruFocus.com
Milestone Scientific Inc (MLSS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo Finance
Q3 2024 Milestone Scientific Inc Earnings Call Transcript - GuruFocus.com
Milestone Scientific Inc (MLSS) Quarterly 10-Q Report - Quartz
Milestone Scientific CEO to retire, interim successor named By Investing.com - Investing.com Australia
Milestone Scientific earnings missed by $0.01, revenue fell short of estimates - Investing.com UK
Milestone Scientific CEO to retire, interim successor named - Investing.com India
Milestone Scientific CEO Haverhals to Exit; Chairman Goldman Named Interim CEO - MarketWatch
Milestone Scientific Achieves 22% Increase in Revenue for the Third Quarter of 2024 - The Manila Times
Milestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEO - The Manila Times
Milestone Scientific Q3 Revenue Jumps 22% on Strong International Dental Sales Growth | MLSS Stock News - StockTitan
Milestone Scientific Announces Leadership Transition and Future Plans - TipRanks
Milestone Scientific Inc (MLSS) Q3 2024: Everything You Need To Know Ahead Of Earnings - GuruFocus.com
Milestone Scientific Schedules Third Quarter 2024 Financial Results and Business Update Conference Call - The Manila Times
Milestone Scientific (MLSS) to Host Q3 2024 Earnings Call on November 15 | MLSS Stock News - StockTitan
Semler Scientific stock hits 52-week high at $53.39 - Investing.com
Milestone Scientific (NYSE:MLSS) Now Covered by StockNews.com - MarketBeat
Critical Comparison: Pathfinder Cell Therapy (OTCMKTS:PFND) versus Milestone Scientific (NYSE:MLSS) - Defense World
Milestone Scientific (NYSE:MLSS) Earns Hold Rating from Analysts at StockNews.com - MarketBeat
Milestone Scientific Expands Commercial Rollout of the CompuFlo® Epidural System with Esteemed Pain Management Physician Dr. Elbaz at Hudson Specialty Care - ForexTV.com
Milestone Scientific expands commercial rollout of CompuFlo Epidural System - TipRanks
Lyell Immunopharma Completes Acquisition of ImmPACT Bio - ForexTV.com
Fellow Health Celebrates Milestone of 100,000 Patient Tests - Business Wire
SafetyVue, Inc. Celebrates Milestone Achievements in Construction Safety Training - Yahoo Finance
Health Care | Page 612 of 616 - ROI-NJ.com
Scientific - ழ தொலைக்காட்சி
Milestone Scientific (NYSE:MLSS) Receives New Coverage from Analysts at StockNews.com - MarketBeat
Start-up claims to have ‘successfully’ achieved first ‘chat’ between two dreaming humans: ‘Could unlock new dimensions’ - New York Post
Benchmark Initiates Coverage of Milestone Scientific (MLSS) with Speculative Buy Recommendation - MSN
Milestone Scientific director Leonard Osser sells stock for $100,425 By Investing.com - Investing.com Australia
Milestone Scientific director Leonard Osser sells stock for $100,425 - Investing.com
Leonard Osser Sells 107,984 Shares of Milestone Scientific Inc. (NYSE:MLSS) Stock - MarketBeat
Retina implant partially improved eyesight in people with severe vision loss - STAT
Science Corp’s PRIMA Implant Restores Vision in Preliminary Clinical Trial Results - Business Wire
Milestone Scientific (NYSE:MLSS) Coverage Initiated at StockNews.com - MarketBeat
Finanzdaten der Milestone Scientific Inc.-Aktie (MLSS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.43%
0.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):